1. Home
  2. RHI vs ICUI Comparison

RHI vs ICUI Comparison

Compare RHI & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Robert Half Inc.

RHI

Robert Half Inc.

SELL

Current Price

$46.41

Market Cap

3.9B

ML Signal

SELL

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$167.07

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RHI
ICUI
Founded
1948
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.0B
IPO Year
1994
1995

Fundamental Metrics

Financial Performance
Metric
RHI
ICUI
Price
$46.41
$167.07
Analyst Decision
Hold
Buy
Analyst Count
11
8
Target Price
$35.00
★ $193.38
AVG Volume (30 Days)
★ 1.6M
198.0K
Earning Date
10-22-2026
11-05-2026
Dividend Yield
★ 6.26%
N/A
EPS Growth
N/A
★ 100.62
EPS
0.40
★ 1.96
Revenue
★ $5,378,506,000.00
$2,231,262,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.14
$4.44
P/E Ratio
$94.30
★ $85.69
Revenue Growth
N/A
★ N/A
52 Week Low
$21.83
$113.37
52 Week High
$46.70
$192.85

Technical Indicators

Market Signals
Indicator
RHI
ICUI
Relative Strength Index (RSI) 77.18 55.72
Support Level $35.08 $164.09
Resistance Level N/A $167.67
Average True Range (ATR) 1.75 4.46
MACD 1.12 0.82
Stochastic Oscillator 100.00 85.94

Price Performance

Historical Comparison
RHI
ICUI

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: